RecallDepth
Class II Ongoing

Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01

This recall is currently active, issued June 5, 2024. It was issued by Imprimis Njof, Llc.

Company
Imprimis Njof, Llc
Recall Initiated
May 14, 2024
Posted
June 5, 2024
Recall Number
D-0519-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
74,440 units
Firm Location
Ledgewood, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 23JUL025, Exp. Date 7/17/2024; 23SEP012, Exp. Date 7/11/2024; 23OCT015, Exp. Date 7/20/2024; 23OCT020, Exp. Date 7/25/2024; 23OCT026, Exp. Date 8/22/2024; 23NOV030, Exp. Date 8/29/2024, 23DEC026, Exp. Date 9/29/2024; 24JAN011, Exp. Date 7/21/2024; 24FEB033, Exp. Date 8/24/2024; 24JAN050, Exp. Date 8/30/2024

More recalls by Imprimis Njof, Llc

View all recalls by this company →

Other recent Class II Drug recalls